Newsroom

Oct 26 2016

Love0

An Update on Hepatitis B Therapies [Drug Discovery World]

http://www.ddw-online.com/fall-2016/p315872-an-update-on-hepatitis-b-therapies.html

Oct 14 2016

Love1

Dr. Robert Foster, Chief Scientific Officer of Hepion, invited to join the Faculty of Pharmacy & Pharmaceutical Sciences at the University of Alberta as an Honorary Professor

https://hepionpharma.com/wp-content/uploads/2016/07/RTF-Professorship.pdf

Oct 11 2016

Love0

The Rise of the CFO Strategist: Balancing Numbers and Know-how [Via PharmaExec]

http://www.pharmexec.com/rise-cfo-strategist-balancing-numbers-and-know-how

Jul 25 2016

Love0

Hepion Hopes To Establish Backbone For Hepatitis B Combo Therapy [via Scrip]

https://scrip.pharmamedtechbi.com/SC096933/Hepion-Hopes-To-Establish-Backbone-For-Hepatitis-B-Combo-Therapy

Mar 30 2016

Love1

Should Gilead Sciences Feel Threatened By Hepion’s Hepatitis B Drug? [via Bidness Etc]

http://www.bidnessetc.com/66362-gilead-sciences-feel-threatened-contravirs-hepatitis-b-drug/

Feb 04 2015

Love1

Hepatitis Quest Moves From C to B Under Ex-Gilead Leaders [via Bloomberg Business]

http://www.bloomberg.com/news/articles/2015-02-04/hepatitis-quest-moves-from-c-to-b-under-former-gilead-executives

Dec 18 2014

Love0

Hepion Obtains HBV Candidate, Investment from Chimerix

http://www.biocentury.com/dailynews/company/2014-12-18/contravir-obtains-hbv-candidate-investment-from-chimerix